Company: HCTI
Filing Date: 2025-05-20
Form Type: 10-Q
Source: 0001213900-25-045994
Chunk: 32

Company: Healthcare Triangle, Inc.
Filing Date: 2025-05-20
Form: 10-Q
Item: Part I, Item 1
Chunk 32
---
 our unvested options
for the year ended March 31, 2025

    Number of  
    Weighted 
average 
Grant Date 
Fair Value 

    Shares  
    Per Share 
  
    Unvested on January 1, 2025 
     35,849  
    $1.88 
  
    Granted 
     -  
     - 
  
    Vested 
     (35,849) 
     1.88 
  
    Forfeited 
     -  
     - 
  
    Unvested on March 31, 2025 
     -  
    $- 

The following table summarizes the activities for our unvested options
for the year ended March 31, 2024

    Number of  
    Weighted 
average
 Grant Date 
Fair Value 

    Shares  
    Per Share 
  
    Unvested on January 1, 2024 
     46,928  
    $2.24 
  
    Granted 
     -  
     - 
  
    Vested 
     (31,496) 
     0.80 
  
    Forfeited 
     (3,000) 
     3.50 
  
    Unvested on March 31, 2024 
     75,424  
    $1.59 

The weighted-average grant date fair value of
options granted during the quarter ended March 31, 2025, was $0 and $0 during the quarter ended March 31, 2024. The total fair value of
the vested options as of March 31, 2025, and March 31, 2024, were $ 911 and $576 respectively.

As of March 31, 2025, there was $36 of unrecognized
share-based compensation expense related to unvested options. This unrecognized compensation expense is expected to be recognized over
a weighted-average period of approximately two years based on vesting under the award service conditions.

Schedule of assumptions

    Fair value assumptions 
    2024  
    2023 
  
    Expected volatility 
     45%-52 % 
     45%-52 %
  
    Expected terms (in years) 
     4  
     4 
  
    Risk-free interest rate 
     4.70%-5.70 %